ambroxol; ambroxolum

From Aaushi

Jump to navigation Jump to search

^[1]^[2]

Indications

experimental drug for Parkinson's disease^[2]

Pharmacokinetics

crosses blood brain barrier

Mechanism of action

mucolytic agent
increases beta-glucocerebrosidase & alpha synuclein levels in CSF

More general terms

mucolytic agent

References

↑ PubChem: 2132
↑ ^2.0 ^2.1 Nackerdien Z Repurposed Mucolytic Shows Promise for Neuroprotection in Parkinson's Disease.
Changes in GCase levels occurred in patients with and without GBA1 mutations. MedPage Today. anuary 29, 2020 https://www.medpagetoday.org/neurology/parkinsonsdisease/84594

Database

PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=2132

Retrieved from "https://aaushi.info/w/index.php?title=A55953&oldid=916485"

↑ Back to top